Selected article for: "cell plasma and high affinity"

Author: Kato, Yu; Abbott, Robert K.; Freeman, Brian L.; Haupt, Sonya; Groschel, Bettina; Silva, Murillo; Menis, Sergey; Irvine, Darrell J.; Schief, William R.; Crotty, Shane
Title: Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
  • Cord-id: 93srmihg
  • Document date: 2020_8_27
  • ID: 93srmihg
    Snippet: How antigen valency affects B cells in vivo during immune responses is not well understood. Here, using HIV immunogens with defined valencies ranging from 1 to 60, we investigated the role of antigen valency during different phases of B cell responses in vivo. Highly multimerized immunogens preferentially rapidly activated cognate B cells, with little affinity discrimination. This led to strong early induction of the transcription factors IRF4 (interferon regulatory factor 4) and Bcl6, driving b
    Document: How antigen valency affects B cells in vivo during immune responses is not well understood. Here, using HIV immunogens with defined valencies ranging from 1 to 60, we investigated the role of antigen valency during different phases of B cell responses in vivo. Highly multimerized immunogens preferentially rapidly activated cognate B cells, with little affinity discrimination. This led to strong early induction of the transcription factors IRF4 (interferon regulatory factor 4) and Bcl6, driving both early extrafollicular plasma cell and germinal center responses, in a CD4(+) T-cell-dependent manner, involving B cells with a broad range of affinities. Low-valency antigens induced smaller effector B cell responses, with preferential recruitment of high-affinity B cells. Thus, antigen valency has multifaceted effects on B cell responses and can dictate affinity thresholds and competitive landscapes for B cells in vivo, with implications for vaccine design.

    Search related documents:
    Co phrase search for related documents
    • acute sars cov respiratory syndrome coronavirus and additional metric: 1
    • acute sars cov respiratory syndrome coronavirus and adjuvant absence: 1
    • acute sars cov respiratory syndrome coronavirus and adjuvant immunogens: 1
    • acute sars cov respiratory syndrome coronavirus and adoptive transfer: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and adoptively transfer: 1